This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec 12;374(9706):1950-1.

doi: 10.1016/S0140-6736(09)61838-9.

Enzyme therapy for Fabry's disease: registered for success?

Bertrand Knebelmann¹, Christine Kurschat, Ravi Thadhani

Affiliations

PMID: 19959220
DOI: 10.1016/S0140-6736(09)61838-9

Comment

Enzyme therapy for Fabry's disease: registered for success?

Bertrand Knebelmann et al. Lancet. 2009.

. 2009 Dec 12;374(9706):1950-1.

doi: 10.1016/S0140-6736(09)61838-9.

Authors

Bertrand Knebelmann¹, Christine Kurschat, Ravi Thadhani

Affiliation

¹ Necker Hospital, APHP, Paris Descartes University, Paris, France.

PMID: 19959220
DOI: 10.1016/S0140-6736(09)61838-9

No abstract available

PubMed Disclaimer

Comment on

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.
Mehta A, Beck M, Elliott P, Giugliani R, Linhart A, Sunder-Plassmann G, Schiffmann R, Barbey F, Ries M, Clarke JT; Fabry Outcome Survey investigators. Mehta A, et al. Lancet. 2009 Dec 12;374(9706):1986-96. doi: 10.1016/S0140-6736(09)61493-8. Lancet. 2009. PMID: 19959221

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- Genetic Alliance